IBDEI30G ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48078,0)
 ;;=E34.9^^185^2417^57
 ;;^UTILITY(U,$J,358.3,48078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48078,1,3,0)
 ;;=3^Endocrine Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,48078,1,4,0)
 ;;=4^E34.9
 ;;^UTILITY(U,$J,358.3,48078,2)
 ;;=^5002777
 ;;^UTILITY(U,$J,358.3,48079,0)
 ;;=R62.7^^185^2417^58
 ;;^UTILITY(U,$J,358.3,48079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48079,1,3,0)
 ;;=3^Failure to Thrive,Adult
 ;;^UTILITY(U,$J,358.3,48079,1,4,0)
 ;;=4^R62.7
 ;;^UTILITY(U,$J,358.3,48079,2)
 ;;=^322019
 ;;^UTILITY(U,$J,358.3,48080,0)
 ;;=R63.3^^185^2417^59
 ;;^UTILITY(U,$J,358.3,48080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48080,1,3,0)
 ;;=3^Feeding Difficulty
 ;;^UTILITY(U,$J,358.3,48080,1,4,0)
 ;;=4^R63.3
 ;;^UTILITY(U,$J,358.3,48080,2)
 ;;=^5019541
 ;;^UTILITY(U,$J,358.3,48081,0)
 ;;=E87.8^^185^2417^60
 ;;^UTILITY(U,$J,358.3,48081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48081,1,3,0)
 ;;=3^Fluid & Electrolyte Balance Disorder NEC
 ;;^UTILITY(U,$J,358.3,48081,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,48081,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,48082,0)
 ;;=E87.70^^185^2417^61
 ;;^UTILITY(U,$J,358.3,48082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48082,1,3,0)
 ;;=3^Fluid Overload,Unspec
 ;;^UTILITY(U,$J,358.3,48082,1,4,0)
 ;;=4^E87.70
 ;;^UTILITY(U,$J,358.3,48082,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,48083,0)
 ;;=R73.01^^185^2417^75
 ;;^UTILITY(U,$J,358.3,48083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48083,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,48083,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,48083,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,48084,0)
 ;;=R73.02^^185^2417^76
 ;;^UTILITY(U,$J,358.3,48084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48084,1,3,0)
 ;;=3^Impaired Oral Glucose Tolerance
 ;;^UTILITY(U,$J,358.3,48084,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,48084,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,48085,0)
 ;;=E83.119^^185^2417^62
 ;;^UTILITY(U,$J,358.3,48085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48085,1,3,0)
 ;;=3^Hemochromatosis,Unspec
 ;;^UTILITY(U,$J,358.3,48085,1,4,0)
 ;;=4^E83.119
 ;;^UTILITY(U,$J,358.3,48085,2)
 ;;=^5002995
 ;;^UTILITY(U,$J,358.3,48086,0)
 ;;=E83.52^^185^2417^63
 ;;^UTILITY(U,$J,358.3,48086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48086,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,48086,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,48086,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,48087,0)
 ;;=E11.65^^185^2417^20
 ;;^UTILITY(U,$J,358.3,48087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48087,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,48087,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,48087,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,48088,0)
 ;;=R73.9^^185^2417^64
 ;;^UTILITY(U,$J,358.3,48088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48088,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,48088,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,48088,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,48089,0)
 ;;=E87.5^^185^2417^66
 ;;^UTILITY(U,$J,358.3,48089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48089,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,48089,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,48089,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,48090,0)
 ;;=E83.41^^185^2417^67
 ;;^UTILITY(U,$J,358.3,48090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48090,1,3,0)
 ;;=3^Hypermagnesemia
